Ausgabe 9/2002
Inhalt (20 Artikel)
Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose: more results from the Paris Prospective Study
B. Balkau, A. Forhan, E. Eschwège
Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial
M. Trento, P. Passera, M. Bajardi, M. Tomalino, G. Grassi, E. Borgo, C. Donnola, F. Cavallo, P. Bondonio, M. Porta
A multi-centre, blinded international trial of the effect of A1 and A2 β-casein variants on diabetes incidence in two rodent models of spontaneous Type I diabetes
P. Beales, R. Elliott, S. Flohé, J. Hill, H. Kolb, P. Pozzilli, G.-S. Wang, H. Wasmuth, F. Scott
The effect of birth weight on glucose tolerance in pigs at 3 and 12 months of age
K. Poore, A. Fowden
Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in atherogenesis in KKAy diabetic mice fed with high cholesterol diet
P. Yu, M. Wang, Y. Deng, H. Fan, L. Shira-Bock
Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice
Q. Wang, P. Brubaker
Underestimation of D-glucose utilisation as judged from the conversion of D-[3-3H]glucose to 3HOH
A. Sener, M.-H. Giroix, W. Malaisse
Improved stability, insulin-releasing activity and antidiabetic potential of two novel N-terminal analogues of gastric inhibitory polypeptide: N-acetyl-GIP and pGlu-GIP
F. O'Harte, V. Gault, J. Parker, P. Harriott, M. Mooney, C. Bailey, P. Flatt
Improved metabolic disorders of insulin receptor-deficient mice by transgenic overexpression of glucokinase in the liver
M. Jackerott, A. Baudry, D. Bucchini, J. Jami, R. Joshi
Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes
A. Antonelli, T. Tuomi, M. Nannipieri, P. Fallahi, C. Nesti, H. Okamoto, L. Groop, E. Ferrannini
The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice
Z.-D. Yang, M. Chen, R. Wu, M. McDuffie, J.-L. Nadler
Total plasma homocysteine is associated with hypertension in Type I diabetic patients
S. Neugebauer, L. Tarnow, C. Stehouwer, T. Teerlink, T. Baba, T. Watanabe, H.-H. Parving
Homocysteine enhances impairment of endothelium-dependent relaxation and guanosine cyclic monophosphate formation in aortae from diabetic rabbits
N. Shukla, C. Thompson, G. Angelini, D. Mikhailidis, J. Jeremy
Non-transmitted maternal HLA DQ2 or DQ8 alleles and risk of Type I diabetes in offspring: the importance of foetal or post partum exposure to diabetogenic molecules
M. Pani, J. Van Autreve, B. Van der Auwera, F. Gorus, K. Badenhoop
Rare variants identified in the HNF-4α β-cell-specific promoter and alternative exon 1 lack biological significance in maturity onset diabetes of the young and young onset Type II diabetes
S. Mitchell, M. Vaxillaire, H. Thomas, M. Parrizas, Y. Benmezroua, A. Costa, T. Hansen, K. Owen, T. Tuomi, F. Pirie, G. Ryffel, J. Ferrer, P. Froguel, A. Hattersley, T. Frayling